Investing
Amgen sues Novartis to block generic osteoporosis, bone cancer drugs
© Reuters. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith
2/2
By Blake Brittain
(Reuters) – Amgen Inc (NASDAQ:) sued Novartis AG’s Sandoz in New Jersey federal court Monday, accusing Sandoz’s proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents.
Amgen asked the court to block Sandoz’s biosimilars of the drugs until its patents expire. One of the patents named in the complaint does not expire until 2037.
Sandoz declined to comment on the lawsuit Tuesday. Novartis, which is also named in the complaint, is preparing to spin Sandoz off into a standalone company later this year.
Amgen’s Prolia is used to treat osteoporosis. Xgeva, with the same active ingredient denosumab, treats bone cancer and prevents fractures in bone-cancer patients.
The U.S. Food and Drug Administration approved both drugs in 2010. Thousand Oaks, California-based Amgen sold $3.6 billion worth of Prolia and $2 billion worth of Xgeva last year, according to a company report.
The FDA accepted Sandoz’s application for biosimilar versions of the Amgen biologic drugs — which are derived from living cells, unlike traditional small-molecule drugs — in February.
Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Read the full article here
-
Side Hustles7 days ago
3 Steps You Can’t Miss When Growing Your Business
-
Investing7 days ago
How I Transformed My Business by Letting Go of Low-Value Tasks
-
Side Hustles6 days ago
How to Develop Empowered Leaders Within Your Own Team
-
Side Hustles4 days ago
How to Be Unapologetically You and Why It Matters
-
Passive Income5 days ago
Are You Running Your Business, or Is Your Business Running You?
-
Investing5 days ago
7 Marketing Strategies to Help Your Startup Grow and Scale
-
Side Hustles5 days ago
How Your Body Language Can Help Win a Disagreement
-
Passive Income7 days ago
CVS Is Laying Off Thousands in Cost Cutting Initiative